Page 124 - Read Online

Vidoni et al. J Cancer Metastasis Treat 2021;7:4 I http://dx.doi.org/10.20517/2394-4722.2020.95 Page 17 of 20

2019;8:7018-31.
28. Casey MJ, Summers GK, Crotzer D. Endometrial Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK525981/. [Last accessed on 24 Dec 2020]
29. Matias-Guiu X, Prat J. Molecular pathology of endometrial carcinoma. Histopathology 2013;62:111-23.
30. Dowty JG, Win AK, Buchanan DD, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013;34:490-7.
31. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumors of the female reproductive organs. WHO
classification of tumors. Lyon: IARC press; 2014.
32. Santaballa A, Matías-Guiu X, Redondo A, et al. SEOM clinical guidelines for endometrial cancer (2017). Clin Transl Oncol 2018;20:29-37.
33. Passarello K, Kurian S, Villanueva V. Endometrial Cancer: An Overview of Pathophysiology, Management, and Care. Semin Oncol Nurs
2019;35:157-65.
34. Duenas-Gonzalez A, Gonzalez-Fierro A. Pharmacodynamics of current and emerging treatments for cervical cancer. Expert Opin Drug
Metab Toxicol 2019;15:671-82.
35. Fowler JR, Jack BW. Cancer, Cervical. [Updated 2019 Sep 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK431093/. [Last accessed on 24 Dec 2020]
36. Wang XL, Huang XM, Zhang YZ. Involvement of human papillomaviruses in cervical cancer. Front Microbiol 2018;9:2896.
37. Ghosh I, Mandal R, Kundu P, Biswas J. Association of genital infections other than human papillomavirus with pre-invasive and invasive
cervical neoplasia. J Clin Diagn Res 2016;10:XE01-6.
38. Rerucha CM, Caro RJ, Wheeler VL. Cervical cancer screening. Am Fam Physician 20181;97:441-8.
39. Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 2011;80:125-56.
40. Galluzzi L, Baehrecke EH, Ballabio A, et al. Molecular definitions of autophagy and related processes. EMBO J 2017;36:1811-36.
41. Jiang P, Mizushima N. Autophagy and human diseases. Cell Res 2014;24:69-79.
42. Ravanan P, Srikumar IF, Talwar P. Autophagy: the spotlight for cellular stress responses. Life Sci 2017;188:53-67.
43. Hansen M, Rubinsztein DC, Walker DW. Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol
2018;19:579-93.
44. Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett
1993;333:169-74.
45. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013;368:651-62.
46. Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy 2018;14:207-15.
47. Saha S, Panigrahi DP, Patil S, Bhutia SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother
2018;104:485-95.
48. Huang T, Song X, Yang Y, et al. Autophagy and hallmarks of cancer. Crit Rev Oncog 2018;23:247-67.
49. Corona Velazquez AF, Jackson WT. So many roads: the multifaceted regulation of autophagy induction. Mol Cell Biol 2018;38:e00303-18.
50. Follo C, Vidoni C, Morani F, Ferraresi A, Seca C, Isidoro C. Amino acid response by Halofuginone in Cancer cells triggers autophagy
through proteasome degradation of mTOR. Cell Commun Signal 2019;17:39.
51. Polson HE, de Lartigue J, Rigden DJ, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively
regulates LC3 lipidation. Autophagy 2010;6:506-22.
52. Geng J, Klionsky DJ. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. ‘Protein modifications: beyond the
usual suspects’ review series. EMBO Rep 2008;9:859-64.
53. Feinberg AP. The Key Role of epigenetics in human disease prevention and mitigation. N Engl J Med 2018;378:1323-34.
54. Long HK, King HW, Patient RK, Odom DT, Klose RJ. Protection of CpG islands from DNA methylation is DNA-encoded and
evolutionarily conserved. Nucleic Acids Res 2016;44:6693-706.
55. Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 2014;6:a018713.
56. Sanaei M, Kavoosi F. Histone Deacetylases and histone deacetylase inhibitors: molecular mechanisms of action in various cancers. Adv
Biomed Res 2019;8:63.
57. Borley J, Brown R. Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer. Ann Med
2015;47:359-69.
58. Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature 2012;489:101-8.
59. Ozsolak F, Poling LL, Wang Z, et al. Chromatin structure analyses identify miRNA promoters. Genes Dev 2008;22:3172-83.
60. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol
(Lausanne) 2018;9:402.
61. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012;482:339-46.
62. Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics
Bioinformatics 2017;15:177-86.
63. Milligan MJ, Lipovich L. Pseudogene-derived lncRNAs: emerging regulators of gene expression. Front Genet 2014;5:476.
64. Wei JW, Huang K, Yang C, Kang CS. Non-coding RNAs as regulators in epigenetics (Review). Oncol Rep 2017;37:3-9.
65. Noh JH, Kim KM, McClusky WG, Abdelmohsen K, Gorospe M. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip Rev
RNA 2018;9:e1471.
66. Shao Y, Chen Y. Roles of Circular RNAs in Neurologic Disease. Front Mol Neurosci 2016;9:25.
67. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013;19:141-57.
68. Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochim Biophys Acta 2016;1859:163-8.